EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy

Sang-Hyeon Hann iD, Seon-Yong Kim, Ye Lynne Kim, Young-Woo Jo, Jong-Seol Kang, Hyerim Park, Se-Young Choi iD, Young-Yun Kong iD

eLife · 2024

DOI: 10.7554/elife.92731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Sang-Hyeon Hann und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Neuromuscular Diseases, Survival of Motor Neuron 1 Protein. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal muscular atrophy (SMA) is a neuromuscular disorder characterized by the deficiency of the survival motor neuron (SMN) protein, which leads to motor neuron dysfunction and muscle atrophy. In addition to the requirement for SMN in motor neurons, recent studies suggest that SMN deficiency in peripheral tissues plays a key role in the pathogenesis of SMA. Using limb mesenchymal progenitor cell (MPC)-specific SMN-depleted mouse models, we reveal that SMN reduction in limb MPCs causes defects in the development of bone and neuromuscular junction (NMJ). Specifically, these mice exhibited impaired growth plate homeostasis and reduced insulin-like growth factor (IGF) signaling from chondrocytes, rather than from the liver. Furthermore, the reduction of SMN in fibro-adipogenic progenitors (FAPs) resulted in abnormal NMJ maturation, altered release of neurotransmitters, and NMJ morphological defects. Transplantation of healthy FAPs rescued the morphological deterioration. Our findings highlight the significance of mesenchymal SMN in neuromusculoskeletal pathogenesis of SMA and provide insights into potential therapeutic strategies targeting mesenchymal cells for the treatment of SMA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Atrophy, SpinalNeuromuscular DiseasesSurvival of Motor Neuron 1 ProteinAnimalsMiceDisease Models, AnimalMotor NeuronsNeuromuscular JunctionTranscription Factors

Stichwörter der Autor:innen

IGF signalingchondrocytefibro-adipogenic progenitorgrowth platemedicinemouseneuromuscular junctionneurosciencespinal muscular atrophy

Substanzen

Transcription FactorsSmn1 protein, mouseSurvival of Motor Neuron 1 Protein

Autor:innen und Institutionen

  • School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Department of Physiology, Dental Research Institute, Seoul National University School of Dentistry, Seoul, Republic of Korea.

ORCID-Profile: Sang-Hyeon Hann, Se-Young Choi, Young-Yun Kong

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Hann, S. H., Kim, S. Y., Kim, Y. L., Jo, Y. W., Kang, J. S., Park, H., Choi, S. Y., & Kong, Y. Y. (2024). Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy. eLife. https://doi.org/10.7554/elife.92731

Vancouver

Hann SH, Kim SY, Kim YL, Jo YW, Kang JS, Park H, et al. Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy. eLife. 2024. doi:10.7554/elife.92731

BibTeX
@article{Hann2024,
  author = {Hann, Sang-Hyeon and Kim, Seon-Yong and Kim, Ye Lynne and Jo, Young-Woo and Kang, Jong-Seol and Park, Hyerim and Choi, Se-Young and Kong, Young-Yun},
  title = {Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.92731}
}
Kostenlos starten →